bioRxivMicrobiologyPreprint
The Impact of Pf Bacteriophages on the Fitness of Pseudomonas aeruginosa; A Mathematical Modeling Approach
J. D. Pourtois, M. J. Kratochvil, Q. Chen, N. L. Haddock, E. B. Burgener, G. A. De Leo, P. L. Bollyky
Abstract
Pseudomonas aeruginosa (Pa) is a major bacterial pathogen responsible for chronic lung infections in cystic fibrosis patients. Recent work by ourselves and others has implicated Pf bacteriophages, non-lytic filamentous viruses produced by Pa, in the chronicity and severity of Pa infections. Pf phages act as structural elements in Pa biofilms and sequester aerosolized antibiotics, thereby contributing to antibiotic tolerance. Consistent with a selective advantage in this setting, the prevalence of Pf+ bacteria increases over time in these patients. However, the production of Pf phages comes at a metabolic cost to bacteria, such that Pf+ strains grow more slowly than Pf- strains in vitro. Here, we use a mathematical model to investigate how these competing pressures might influence the relative abundance of Pf+ versus Pf- strains in different settings. Our model predicts that Pf+ strains of Pa can only outcompete Pf- strains if the benefits of phage production falls solely onto Pf+ strains and not onto the overall bacterial community in the lung. Further, phage production only leads to a net positive gain in fitness at antibiotic concentrations slightly above the minimum inhibitory concentration (i.e., concentrations for which the benefits of antibiotic sequestration outweigh the metabolic cost of phage production), but which are not lethal for Pf+ strains. As a result, our model predicts that frequent administration of intermediate doses of antibiotics with low decay rates favors Pf+ over Pf- strains. These models inform our understanding of the ecology of Pf phages and suggest potential treatment strategies for Pf+ Pa infections. ImportanceFilamentous phages are a frontier in bacterial pathogenesis, but the impact of these phages on bacterial fitness is unclear. In particular, Pf phages produced by Pa promote antibiotic tolerance but are metabolically expensive to produce, suggesting that competing pressures may influence the prevalence of Pf+ versus Pf- strains of Pa in different settings. Our results identify conditions likely to favor Pf+ strains and thus antibiotic tolerance. This study contributes to a better understanding of the unique ecology of filamentous phages and may facilitate improved treatment strategies for combating antibiotic tolerance.
- organism: bacteria (other)
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding
Q. Chen, P. Cai, … P. L. Bollyky·bioRxiv·Mar 10, 2024
- Involvement of Pf-like phages in resistance to phage infection in clinical isolates of P. aeruginosa from cystic fibrosis patients
Lucía Blasco, Antonio Barrio-Pujante, … María Tomás·Microbiology SpectrumPeer-reviewed·Feb 5, 2025
- Filamentous cheater phages drive bacterial and phage populations to lower fitness
Nanami Kubota, Michelle R. Scribner, Vaughn S. Cooper·Current BiologyPeer-reviewed·Oct 4, 2025
- Phage-phage competition and biofilms reduce the efficacy of a combination of two virulent bacteriophages against Pseudomonas aeruginosa
Magdalena Bürkle, Imke H. E. Korf, … Krishnamoorthy Gopinath·The ISME JournalPeer-reviewed·Jan 1, 2025
- Targeted deletion of Pf prophages from diverse Pseudomonas aeruginosa isolates impacts quorum sensing and virulence traits
A. K. Schmidt, C. M. Schwartzkopf, … P. R. Secor·bioRxiv·Nov 19, 2023
- Temperate bacteriophage induced in Pseudomonas aeruginosa biofilms can modulate bacteriophage and antibiotic resistance
Mark Grevsen Martinet, Bolaji John Samuel, … Oliwia Makarewicz·BiofilmPeer-reviewed·Nov 20, 2025